The Latent TB Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Latent TB Infection Testing size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Latent TB Infection Testing market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Latent TB Infection Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mantoux Test / Tuberculin Skin Test (TST)
Interferon-Gamma Release Assay (IGRA)
Market segment by Application, can be divided into
Hospitals
Public and Student Health
Physician Offices and Clinics
Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
Market segment by players, this report covers
Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
Pharmstandard (Generium Pharmaceutical)
Sanofi S.A./Sanofi Pasteur Ltd.
Statens Serum Institut (SSI)
Autoimmun Diagnostika (AID) GmbH
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
Immunoshop India Pvt. Ltd.
Qiagen N.V.
Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
SD Biosensor, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Latent TB Infection Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Latent TB Infection Testing, with revenue, gross margin and global market share of Latent TB Infection Testing from 2019 to 2021.
Chapter 3, the Latent TB Infection Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Latent TB Infection Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Latent TB Infection Testing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Latent TB Infection Testing
1.2 Classification of Latent TB Infection Testing by Type
1.2.1 Overview: Global Latent TB Infection Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Latent TB Infection Testing Revenue Market Share by Type in 2020
1.2.3 Mantoux Test / Tuberculin Skin Test (TST)
1.2.4 Interferon-Gamma Release Assay (IGRA)
1.3 Global Latent TB Infection Testing Market by Application
1.3.1 Overview: Global Latent TB Infection Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Public and Student Health
1.3.4 Physician Offices and Clinics
1.3.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
1.4 Global Latent TB Infection Testing Market Size & Forecast
1.5 Global Latent TB Infection Testing Market Size and Forecast by Region
1.5.1 Global Latent TB Infection Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Latent TB Infection Testing Market Size by Region, (2016-2021)
1.5.3 North America Latent TB Infection Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Latent TB Infection Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Latent TB Infection Testing Market Size and Prospect (2016-2026)
1.5.6 South America Latent TB Infection Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Latent TB Infection Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Latent TB Infection Testing Market Drivers
1.6.2 Latent TB Infection Testing Market Restraints
1.6.3 Latent TB Infection Testing Trends Analysis
2 Company Profiles
2.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
2.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Details
2.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Major Business
2.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product and Solutions
2.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments and Future Plans
2.2 Pharmstandard (Generium Pharmaceutical)
2.2.1 Pharmstandard (Generium Pharmaceutical) Details
2.2.2 Pharmstandard (Generium Pharmaceutical) Major Business
2.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product and Solutions
2.2.4 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pharmstandard (Generium Pharmaceutical) Recent Developments and Future Plans
2.3 Sanofi S.A./Sanofi Pasteur Ltd.
2.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Details
2.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Major Business
2.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product and Solutions
2.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments and Future Plans
2.4 Statens Serum Institut (SSI)
2.4.1 Statens Serum Institut (SSI) Details
2.4.2 Statens Serum Institut (SSI) Major Business
2.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Product and Solutions
2.4.4 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Statens Serum Institut (SSI) Recent Developments and Future Plans
2.5 Autoimmun Diagnostika (AID) GmbH
2.5.1 Autoimmun Diagnostika (AID) GmbH Details
2.5.2 Autoimmun Diagnostika (AID) GmbH Major Business
2.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product and Solutions
2.5.4 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Autoimmun Diagnostika (AID) GmbH Recent Developments and Future Plans
2.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
2.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Details
2.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Major Business
2.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product and Solutions
2.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments and Future Plans
2.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
2.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Details
2.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Major Business
2.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product and Solutions
2.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments and Future Plans
2.8 Immunoshop India Pvt. Ltd.
2.8.1 Immunoshop India Pvt. Ltd. Details
2.8.2 Immunoshop India Pvt. Ltd. Major Business
2.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product and Solutions
2.8.4 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Immunoshop India Pvt. Ltd. Recent Developments and Future Plans
2.9 Qiagen N.V.
2.9.1 Qiagen N.V. Details
2.9.2 Qiagen N.V. Major Business
2.9.3 Qiagen N.V. Latent TB Infection Testing Product and Solutions
2.9.4 Qiagen N.V. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Qiagen N.V. Recent Developments and Future Plans
2.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
2.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Details
2.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Major Business
2.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product and Solutions
2.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments and Future Plans
2.11 SD Biosensor, Inc.
2.11.1 SD Biosensor, Inc. Details
2.11.2 SD Biosensor, Inc. Major Business
2.11.3 SD Biosensor, Inc. Latent TB Infection Testing Product and Solutions
2.11.4 SD Biosensor, Inc. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 SD Biosensor, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Latent TB Infection Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Latent TB Infection Testing Players Market Share
3.2.2 Top 10 Latent TB Infection Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Latent TB Infection Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Latent TB Infection Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Latent TB Infection Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Latent TB Infection Testing Revenue Market Share by Application (2016-2021)
5.2 Latent TB Infection Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Latent TB Infection Testing Revenue by Type (2016-2026)
6.2 North America Latent TB Infection Testing Revenue by Application (2016-2026)
6.3 North America Latent TB Infection Testing Market Size by Country
6.3.1 North America Latent TB Infection Testing Revenue by Country (2016-2026)
6.3.2 United States Latent TB Infection Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Latent TB Infection Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Latent TB Infection Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Latent TB Infection Testing Revenue by Type (2016-2026)
7.2 Europe Latent TB Infection Testing Revenue by Application (2016-2026)
7.3 Europe Latent TB Infection Testing Market Size by Country
7.3.1 Europe Latent TB Infection Testing Revenue by Country (2016-2026)
7.3.2 Germany Latent TB Infection Testing Market Size and Forecast (2016-2026)
7.3.3 France Latent TB Infection Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Latent TB Infection Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Latent TB Infection Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Latent TB Infection Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Latent TB Infection Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Latent TB Infection Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Latent TB Infection Testing Market Size by Region
8.3.1 Asia-Pacific Latent TB Infection Testing Revenue by Region (2016-2026)
8.3.2 China Latent TB Infection Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Latent TB Infection Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Latent TB Infection Testing Market Size and Forecast (2016-2026)
8.3.5 India Latent TB Infection Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Latent TB Infection Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Latent TB Infection Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Latent TB Infection Testing Revenue by Type (2016-2026)
9.2 South America Latent TB Infection Testing Revenue by Application (2016-2026)
9.3 South America Latent TB Infection Testing Market Size by Country
9.3.1 South America Latent TB Infection Testing Revenue by Country (2016-2026)
9.3.2 Brazil Latent TB Infection Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Latent TB Infection Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Latent TB Infection Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Latent TB Infection Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Latent TB Infection Testing Market Size by Country
10.3.1 Middle East & Africa Latent TB Infection Testing Revenue by Country (2016-2026)
10.3.2 Turkey Latent TB Infection Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Latent TB Infection Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Latent TB Infection Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Latent TB Infection Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Latent TB Infection Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Latent TB Infection Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Latent TB Infection Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Latent TB Infection Testing Revenue Market Share by Region (2021-2026)
Table 6. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Corporate Information, Head Office, and Major Competitors
Table 7. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Major Business
Table 8. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product and Solutions
Table 9. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pharmstandard (Generium Pharmaceutical) Corporate Information, Head Office, and Major Competitors
Table 11. Pharmstandard (Generium Pharmaceutical) Major Business
Table 12. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product and Solutions
Table 13. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi S.A./Sanofi Pasteur Ltd. Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi S.A./Sanofi Pasteur Ltd. Major Business
Table 16. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product and Solutions
Table 17. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Statens Serum Institut (SSI) Corporate Information, Head Office, and Major Competitors
Table 19. Statens Serum Institut (SSI) Major Business
Table 20. Statens Serum Institut (SSI) Latent TB Infection Testing Product and Solutions
Table 21. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Autoimmun Diagnostika (AID) GmbH Corporate Information, Head Office, and Major Competitors
Table 23. Autoimmun Diagnostika (AID) GmbH Major Business
Table 24. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product and Solutions
Table 25. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Major Business
Table 28. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product and Solutions
Table 29. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Corporate Information, Head Office, and Major Competitors
Table 31. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Major Business
Table 32. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product and Solutions
Table 33. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Immunoshop India Pvt. Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Immunoshop India Pvt. Ltd. Major Business
Table 36. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product and Solutions
Table 37. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 39. Qiagen N.V. Major Business
Table 40. Qiagen N.V. Latent TB Infection Testing Product and Solutions
Table 41. Qiagen N.V. Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Corporate Information, Head Office, and Major Competitors
Table 43. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Major Business
Table 44. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product and Solutions
Table 45. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. SD Biosensor, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. SD Biosensor, Inc. Major Business
Table 48. SD Biosensor, Inc. Latent TB Infection Testing Product and Solutions
Table 49. SD Biosensor, Inc. Latent TB Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Latent TB Infection Testing Revenue (USD Million) by Players (2019-2021)
Table 51. Global Latent TB Infection Testing Revenue Share by Players (2019-2021)
Table 52. Breakdown of Latent TB Infection Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Latent TB Infection Testing Players Head Office, Products and Services Provided
Table 54. Latent TB Infection Testing Mergers & Acquisitions in the Past Five Years
Table 55. Latent TB Infection Testing New Entrants and Expansion Plans
Table 56. Global Latent TB Infection Testing Revenue (USD Million) by Type (2016-2021)
Table 57. Global Latent TB Infection Testing Revenue Share by Type (2016-2021)
Table 58. Global Latent TB Infection Testing Revenue Forecast by Type (2021-2026)
Table 59. Global Latent TB Infection Testing Revenue by Application (2016-2021)
Table 60. Global Latent TB Infection Testing Revenue Forecast by Application (2021-2026)
Table 61. North America Latent TB Infection Testing Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Latent TB Infection Testing Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Latent TB Infection Testing Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Latent TB Infection Testing Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Latent TB Infection Testing Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Latent TB Infection Testing Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Latent TB Infection Testing Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Latent TB Infection Testing Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Latent TB Infection Testing Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Latent TB Infection Testing Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Latent TB Infection Testing Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Latent TB Infection Testing Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Latent TB Infection Testing Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Latent TB Infection Testing Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Latent TB Infection Testing Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Latent TB Infection Testing Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Latent TB Infection Testing Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Latent TB Infection Testing Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Latent TB Infection Testing Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Latent TB Infection Testing Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Latent TB Infection Testing Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Latent TB Infection Testing Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Latent TB Infection Testing Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Latent TB Infection Testing Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Latent TB Infection Testing Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Latent TB Infection Testing Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Latent TB Infection Testing Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Latent TB Infection Testing Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Latent TB Infection Testing Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Latent TB Infection Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Latent TB Infection Testing Picture
Figure 2. Global Latent TB Infection Testing Revenue Market Share by Type in 2020
Figure 3. Mantoux Test / Tuberculin Skin Test (TST)
Figure 4. Interferon-Gamma Release Assay (IGRA)
Figure 5. Latent TB Infection Testing Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Public and Student Health Picture
Figure 8. Physician Offices and Clinics Picture
Figure 9. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Picture
Figure 10. Global Latent TB Infection Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Latent TB Infection Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Latent TB Infection Testing Revenue Market Share by Region (2016-2026)
Figure 13. Global Latent TB Infection Testing Revenue Market Share by Region in 2020
Figure 14. North America Latent TB Infection Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Latent TB Infection Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Latent TB Infection Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Latent TB Infection Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Latent TB Infection Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Latent TB Infection Testing Market Drivers
Figure 20. Latent TB Infection Testing Market Restraints
Figure 21. Latent TB Infection Testing Market Trends
Figure 22. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments and Future Plans
Figure 23. Pharmstandard (Generium Pharmaceutical) Recent Developments and Future Plans
Figure 24. Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments and Future Plans
Figure 25. Statens Serum Institut (SSI) Recent Developments and Future Plans
Figure 26. Autoimmun Diagnostika (AID) GmbH Recent Developments and Future Plans
Figure 27. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments and Future Plans
Figure 28. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments and Future Plans
Figure 29. Immunoshop India Pvt. Ltd. Recent Developments and Future Plans
Figure 30. Qiagen N.V. Recent Developments and Future Plans
Figure 31. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments and Future Plans
Figure 32. SD Biosensor, Inc. Recent Developments and Future Plans
Figure 33. Global Latent TB Infection Testing Revenue Share by Players in 2020
Figure 34. Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Latent TB Infection Testing Revenue Market Share in 2020
Figure 36. Global Top 10 Players Latent TB Infection Testing Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Latent TB Infection Testing Revenue Share by Type in 2020
Figure 39. Global Latent TB Infection Testing Market Share Forecast by Type (2021-2026)
Figure 40. Global Latent TB Infection Testing Revenue Share by Application in 2020
Figure 41. Global Latent TB Infection Testing Market Share Forecast by Application (2021-2026)
Figure 42. North America Latent TB Infection Testing Sales Market Share by Type (2016-2026)
Figure 43. North America Latent TB Infection Testing Sales Market Share by Application (2016-2026)
Figure 44. North America Latent TB Infection Testing Revenue Market Share by Country (2016-2026)
Figure 45. United States Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Latent TB Infection Testing Sales Market Share by Type (2016-2026)
Figure 49. Europe Latent TB Infection Testing Sales Market Share by Application (2016-2026)
Figure 50. Europe Latent TB Infection Testing Revenue Market Share by Country (2016-2026)
Figure 51. Germany Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Latent TB Infection Testing Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Latent TB Infection Testing Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Latent TB Infection Testing Revenue Market Share by Region (2016-2026)
Figure 59. China Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Latent TB Infection Testing Sales Market Share by Type (2016-2026)
Figure 66. South America Latent TB Infection Testing Sales Market Share by Application (2016-2026)
Figure 67. South America Latent TB Infection Testing Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Latent TB Infection Testing Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Latent TB Infection Testing Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Latent TB Infection Testing Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Latent TB Infection Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source